Skeletal muscle function in COPD

Chest

Volumn 117, Issue 5 SUPPL. 1, 2000, Pages 267S-271S

  Casaburi, Richard ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Anabolic; COPD; Exercise; Growth hormone; Muscle; Strength; Testosterone

Indexed keywords

GROWTH HORMONE;

BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; EXERCISE; HORMONAL THERAPY; HUMAN; MOBILIZATION; MUSCLE FUNCTION; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0034043647     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.5_suppl_1.267S-a     Document Type: Conference Paper

References (56)

1. Fessler HE, Wise RA. Lung volume reduction surgery: is less really more? Am J Respir Crit Care Med 1999; 159:1031-1035
2. Casaburi R. Exercise training in chronic obstructive lung disease. In: Casaburi R, Petty TL, eds. Principles and practice of pulmonary rehabilitation. Philadelphia, PA: WB Saunders, 1993; 204-224
3. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159:S1-S40
4. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure Eur Respir J 1990; 3:192-196
5. Whittom F, Jobin J, Simard P-M, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 1998; 30:1467-1474
6. Satta A, Migliori GB, Spanevello A, et al. Fiber types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10:2853-2860
7. Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehab 1998; 18:432-437
8. Jakobsson P, Jordfelt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374-377
9. Maltais F, Simard A-A, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-293
10. Schols AMWJ, Wouters EFM, Soeters PB, et al. Body composition by bioelectrical impedance analysis compared to deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53:421-424
11. Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143:9-18
12. Payen JF, Wuyam B, Levy P, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993; 147:592-598
13. Maltais F, Jobin J, Sullivan MJ, et al. Lower limb metabolic and hemodynamic responses during exercise in normal subjects and in COPD. J Appl Physiol 1998; 84:1573-1580
14. Casaburi R, Storer TW, Wasserman K. Mediation of reduced ventilatory response to exercise after endurance training. J Appl Physiol 1987; 63:1533-1538
15. Gallager CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med 1994; 15:305-326
16. Nery LE, Wasserman K, Andrews JD, et al. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol 1982; 53:1594-1602
17. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of severe COPD patients. Am J Respir Crit Care Med 1997; 155:1541-1551
18. Casaburi R. Deconditioning. In: Fishman AP, ed. Pulmonary rehabilitation. New York, NY: Marcel Dekker, 1996; 213-230
19. Mercier JR, Hokanson JF, Brooks GA. Effects of cyclosporin A on skeletal muscle mitochondrial respiration and endurance times in rats. Am J Respir Crit Care Med 1995; 151:1848-1851
20. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29:197-206
21. Rochester DF. Nutritional repletion. Semin Respir Med 1992; 13:44-52
22. Schols AM, Buurman WA, Staal van den Brekel, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819-824
23. LeRoith D, Adama M, Werner H, et al. Insulin-like growth factors and their receptors as growth regulators in normal physiology and pathologic states. Trends Endocrinol Metab 1991; 2:134-139
24. Sinha-Hikim I, Arver S, Beall G, et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998; 83:1312-1318
25. Davis SR, Burger HG. The rationale for physiological testosterone replacement in women. Bailliere's Clin Endrocrinol Metab 1998; 12:391-405
26. Davidson JM, Chen JJ, Crapo L, et al. Hormonal changes and sexual function in aging men. J Clin Endrocrinol Metab 1983; 57:71-77
27. Rudman D, Mattson DE, Nagraj HS. Plasma testosterone in nursing home men. J Clin Epidemiol 1988; 41:231-236
28. Casaburi R, Goren S, Bhasin S. Substantial prevalence of low anabolic hormone levels in COPD patients undergoing rehabilitation [abstract]. Am J Respir Crit Care Med 1996; 153:A128
29. Semple D'AP, Beastall GH, Watson WS, et al. Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci 1980; 58:105-106
30. Shee CD. Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med 1990; 84:229-233
31. DeCramer M, deBock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964
32. Fiaccadori E, Coffrini E, Fracchia C, et al. Hypophosphatemia and phosphorus depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD. Chest 1994; 105:1392-1398
33. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81:518-527
34. Maltais F, Leblanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:442-447
35. Mohsenifar Z, Horak D, Brown HV, et al. Sensitive indices of improvement in a pulmonary rehabilitation program. Chest 1983; 83:189-192
36. Vallet G, Ahmaidi S, Serres I, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997; 10:114-122
37. Casaburi R. Special considerations for exercise training in chronic lung disease. In: ACSM resource manual: guidelines for exercise testing and prescription. 3rd ed. Baltimore, MD: Williams and Wilkins, 1998; 334-338
38. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Med Sci Sports Exerc 1998; 30:975-991
39. Punzal PA, Ries AL, Kaplan RM, et al. Maximum intensity exercise training in patients with chronic obstructive pulmonary disease. Chest 1991; 100:618-623
40. Sipilä S, Suominen H. Effects of strength and endurance training on thigh and leg muscle mass and composition in elderly women. J Appl Physiol 1995; 75:334-340
41. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Grit Care Med 1996; 153:976-980
42. Bernard S, Leblanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Grit Care Med 1998; 158:629-634
43. Cuneo RC, Salomon F, Wiles CM, et al. Growth hormone treatment in growth hormone-deficient adults: I. Effects on muscle mass and strength. J Appl Physiol 1991; 70:688-694
44. Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996; 124:708-716
45. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med 1996; 125:873-882
46. Burdet L, deMuralt B, Schultz Y, et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:1800-1806
47. Mantzoros CS, Moses AL. Whither recombinant human growth hormone? Ann Intern Med 1996; 125:932-934
48. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endrocrinol Metab 1997; 82:407-413
49. Casaburi R, Storer TW, Bhasin S. Testosterone effects on body composition and muscle performance. In: Bhasin S, Gabelnick H, Spieler J, et al, eds. Androgens: biology, pharmacology and clinical applications, New York, NY: Wiley Liss, 1996; 283-288
50. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiological doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335:1-7
51. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome. Ann Intern Med 1998; 129:18-26
52. Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-1274
53. Ferriera EM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114:19-28
54. Bagatell CJ, Bremner WJ. Androgens in men: uses and abuses. N Engl J Med 1996; 334:707-714
55. Rolf C, Nieschlag E. Potential adverse effects of long-term testosterone therapy. Bailliere's Clin Endocrinol Metab 1998; 12:521-534
56. Brinka PJ, Jochen AL, Cuisinier M, et al. Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatric Soc 1995; 43:899-901